Ronnie Ramlogan and Dimitri Gagliardi write about this ESRC-funded collaborative project between the Universities of Manchester and Liverpool which sets out to identify the critical factors affecting the adoption of pharmacogenetics/genomics as part of the NHS treatment regime for cardiovascular diseases.
